As of 12/02/2011 all genes have been moved to the risk factor page where genes and environmental factors are shown together.
|
Site search Loading |
||||||
| Genes associated with schizophrenia are grouped into families relating to their general overall function. The tables link to ENTREZ, OMIM and citations for each gene. Protein/protein interactions are generally culled from information available from the ENTREZ gene hyperlink unless otherwise referenced. (See below for chromosomal region linkage/gene association concordance).BIOCAR7TA pathway links are provided for some genes (see Terms and conditions) and Disclaimer . GeneCards links are with the kind permission of GeneCards.org: ENVIRONMENTAL RISK FACTORS ARE INCLUDED HERE |
Genes2cognition
proteomics: Enhanced Links to genes are provided by
A large number of the protein products of these genes (DLG2, DPYSL2, GRM3, GRM5, GRIN1, GRIN2A, GRIN2B, GRIN2D, GSK3B, HOMER1,HOMER2, LGI1, MOG, NOS1, NDUFV2, PLA2, PLP1, SLC1A2, STX1A, SYNGR1, YWHAH ) are components of the NMDA receptor complex G2C.These and others (CALR, FYN, GABBR1, GAD1, GNAS, GRIA1, GRIA4, GRM3, GRM7, KIF2, NRXN1, NUMBl, PICK1, PDE4B, PIP5K2A, S100B, SLC25A1, SOD2, MAP6, SYN2, SYN3, XRCC1) are components of the postsynaptic density G2C. ADRA1A, ARCVF, APC, DISC1 , DRPLA, NCAM1, NPTN, PAWR, PAX6, RGS4, ZDHHC8, GRIK3, GRIK4 can also be related to elements of the postsynaptic density or the control of NMDA receptor function (see below). About 25% of the genes so far associated with schizophrenia can be related to this complex.
| Genes involved in both Bipolar disorder and schizophrenia | |
| PI3K/AKT signalling, growth factors and related | ANK3, AKT1, BDNF, BMP6, CABIN1, EGFR, FYN, GSK3B, IMPA2, NRG1, PIK3C3, PIK4CA, PIP5K2A, PDLIM5, RGS4, TCF4, WDFY2 |
| Adhesion/ Junctions | CNTNAP2, JAM3, NCAM1, NRXN1 |
| NMDA and glutamate-related | CIT, DAO, DAOA, DTNBP1, GRIA1, GRID1, GRIN1, GRIN2A, GRIN2B, GRIK4, GRM3, GRM4, GRM7, NOS1, NOSIAP, SNAP25, SYN3, SYNJ1 |
| Dopaminergic/Serotonergic | COMT, DRD2, DRD3, HTR2A, HTR5A, HTR6, SLC6A3, SLC6A4,SLC18A1, SLC18A2, MAOA, TDO2, TH |
| GABA | GABRA1, GABRB2, GAD1 |
| Circadian | CLOCK, NPAS2, NR1D1, TIMELESS, PER3 |
| Cytokines | CSF2RB, IL1B, IL1RN, IL6, IL10, TNFA |
| Oxidative and other stress | ND4, NDUFV2, MTHFR, MTHFD, MTR, NOS3 |
| Endoplasmic reticulum stress | XBP1 |
| Miscellaneous | ACE, ABCB1, ABCA13, AGT, APOE, BRD1, C10orf120, CACNA1C, CDKN2A, CHRNA7, DISC1, DPYSL2, FABP7, FBXO38. GLT8D1, GNL3, GPR50, GPR78, hCAP-D3, INTS6, ITIH3, MC5R, MCHR1, MCHR2, MLC1, MMP9, MRCL3, MRLC2, NALCN , NEK4, NPAS3, PB1, PDE4B,PFN4, PPARD, PPP3CC, PSKH1, RELN, S100B, SEMG2, SLIT3, SP4, SST, SYNGR1, TAAR6, TMEM108, TP53I3, TSNAX, TSPAN8, TUBA8, YWHAH, ZNF804A |
Entrez Gene Links |
General Function and protein/protein interactions |
Positive association evidence |
| Genes controlling glutamate receptor agonist availability | ||
| DAO D-amino acid oxidase |
Metabolises the NMDA receptor glycine site agonist D-serine (Chumakov et al., 2002) |
Associated in Chinese, French, German Israeli and Scottish case studies(Chumakov et al., 2002)(Korostishevsky et al., 2004;Liu et al., 2004;Ma et al., 2006;Schumacher et al., 2004) |
| Activates DAO (Chumakov et al., 2002) |
Associated in American, Chinese, French, German and Israeli case studies (Addington et al., 2004;Chumakov et al., 2002;Korostishevsky et al., 2004;Schumacher et al., 2004;Wang et al., 2004). . | |
| SRR Serine racemase GeneCards | Converts L-serine to D-Serine: Binds to PICK1 (Fujii et al., 2005 ) |
Association reported in a Japanese study Morita et al, 2006 |
| CBS cystathionine-beta-synthase | converts homocysteine to cystathionine | Russian study Golimbet at al, 2009 |
| KMO kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | Tryptophan metabolism: related to hynurenate and quinolinate: NMDA antagonists and agonists respectively | Japanese study Aoyama et al, 2006 |
| MTR 5-methyltetrahydrofolate-homocysteine methyltransferase OMIM GeneCards | 5-methyltetrahydrofolate + L-homocysteine
= tetrahydrofolate + L-methionine |
Association reported in a Polish case study Kempisty et al, 2007 |
| MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase OMIM GeneCards | Multifunctional folate metabolism enzyme | Association reported in a Polish case study Kempisty et al, 2007 |
| MTHFR Methylenetetrahydrofolate reductase OMIM 607093 GeneCards |
Controls homocysteine metabolism: Homocysteine stimulates the NMDA receptor via an action at the glutamate binding site but inhibits NMDA effects via an antagonist effect at the glycine binding site (Lipton et al., 1997). |
Significant association reported in a meta-analysis of 10 case studies (Muntjewerff et al., 2005). Homocysteine and NMDA |
| NAALAD2 N-acetylated alpha-linked acidic dipeptidase 2 GeneCards |
Hydrolyses N-acetylaspartylglutamate (NAAG) to glutamate and N-acetyl aspartate. NAAG is both a metabotropic receptor agonist (GRM3) and an NMDA receptor partial agonist (Coyle, 1997) |
Situated at the chromosome 11 breakpoint of the chromosome1/11 translocation reported to associate with schizophrenia (Semple et al., 2001) N-acetylaspartate schizophrenia |
| SLC15A1 solute carrier family 15 (oligopeptide transporter), member 1 (PEPT1) GeneCards |
Dipeptide transporter whose substrates include NAAG, the NAALAD2 substrate (Sala-Rabanal et al, 2006) | Association
reported in Askenazi Jewish families (Fallin et al., 2005) |
| PRODH Proline dehydrogenase |
Proline can be a precursor for glutamate via PRODH (Thompson et al., 1985). |
Association reported in American Chinese and French family studies (Li et al., 2004a;Liu et al., 2002a),(Jacquet et al., 2002). |
| SLC1A2 solute carrier family 1 (glial high affinity glutamate transporter), member 2 OMIM 600300 GeneCards |
Glutamate
and cysteine transporter |
Association reported in a Japanese case study (Deng et al., 2004b). |
| SLC1A4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | Glutamate transporter | Japanese study Deng et al, 2008 |
| SLC1A6 solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Glutamate transporter | Japanese study Deng et al, 2007 |
| SLC6A5 solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | Transports the NMDA receptor co-agonist glycine | Japanese study Deng et al, 2008 |
| SLC17A7 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 (VGLUT1) | Glutamate transporter | Taiwanese study of rare variants Shen et al, 2009 |
| SLC17A6 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 VGLUT2 | Taiwan study Shen et al, 2010 | |
| Table 2: Genes controlling glutamate packaging and release and presynaptic function | ||
| Binds to NOS1 and synapsins (SYN1, SYN2, SYN3) |
Linked in American family and associated in Columbian and Chinese case studies (Brzustowicz et al., 2004;Miranda et al., 2005;Zheng et al., 2005) | |
| Syntaxin binding protein involved in synaptic vesicle exocytosis |
Association reported in a Korean case study (Lee et al., 2005). | |
| Positively
regulates glutamate release and upregulates the expression |
Association reported in multiple case and family studies (Straub et al., 2002;Tang et al., 2003b;van den Oord et al., 2003;Van Den et al., 2003;Williams et al., 2004a). | |
| CMYA5 cardiomyopathy associated 5 | Binds to dysbindin | GWAS 2010 |
| BLOC1S3 biogenesis of lysosome-related organelles complex-1, subunit 3 GeneCards | Components of this complex are involved in the biogenesis of organelles including melanosomes and platelet-dense granules. Includes DTNB1 and MUTED inter alia See HERMANSKY-PUDLAK SYNDROME | Irish studyMorris et al, 2007 |
| MUTED Muted GeneCards | see above. Dysbindin or MUTED knockdown blocks D2 dopamine receptor (DRD2) internalisation, increasing cell surface expression Iizuka et al, 2007 | Irish studyMorris et al, 2007 |
| Transport of synaptic vesicles (Pimm et al., 2005) |
Associated with schizophrenia in a British study (Pimm et al., 2005) and in a chinese family study (Tang et al 2006) | |
| SHANK3 SH3 and multiple ankyrin repeat domains 3 | Postsynaptic density protein Binds to SPTAN1 (DISC1 partner) and PAX6 | Mutations observed in two families Gauthier et al, 2010 |
SNAP25 synaptosomal-associated protein, 25kDa
|
Synaptic vesicle and transmitter release | Irish study Fanous et al, 2010 |
| Syntaxin binding protein involved in glutamate release; Binds to STX1A |
Association reported in an American case study (Saito et al., 2001) | |
| Associated with synaptic vesicles and glutamate release. Binds to CAPON and SYN3 .Expression regulated by DRD1 and DRD2 receptors (Chong et al, 2006) |
Association in Chinese and Korean case studies (Chen et al., 2004a;Lee et al., 2005) and in a family based chinese study {8923} | |
| Associated with synaptic vesicles and glutamate release. Binds to CAPON and SYN2 |
Association reported in American case studies(Lachman et al., 2005;Porton et al., 2004) | |
| SYT11 Synaptotagmin XI GeneCards | Family of memrane trafficking proteins involved in transmitter release | Association reported in a Japanese study Inoue at al, 2007 |
| Function
in vesicle fusion and transmitter release |
Association reported in a Canadian case study (Wong et al., 2004). | |
| Associated with presynaptic vesicles. |
Nonsense mutation in an Indian family (Verma et al., 2004). Association also revealed in non-familial cases (Verma et al., 2005a) | |
| GABBR1 GABA-B receptor 1 |
Agonists
inhibit glutamate release.Binds to ATF4
and ATF5
White
at al, 2000(as does DISC1). |
Weakly associated with schizophrenia in Japanese family and European case studies (Imai et al., 2002) (Zai et al., 2005). |
| GABRG2 gamma-aminobutyric acid (GABA) A receptor, gamma 2 | Canadian study Zai et al, 2009 | |
| GRM3 Metabotropic glutamate receptor mgluR3 OMIM 601115 GeneCards |
Binds to PICK1 . Agonists inhibit glutamate release. |
Association reported in Japanese and Chinese case studies (Fujii et al., 2003) (Chen et al., 2005) and in a family based American study (Egan et al., 2004) |
| GRM4 Metabotropic glutamate receptor mgluR4 OMIM 604100 GeneCards |
Agonists inhibit glutamate release |
Association reported in Ashenazi Jewish families (Fallin et al., 2005) |
| GRM7 glutamate receptor, metabotropic 7 GeneCards | Binds to PICK1 and TUBA8 | Association reported in a Japanese study Ohtsuki et al, 2008 |
| GRM8 Metabotropic glutamate receptor mgluR8 OMIM 601116 GeneCards |
Agonists inhibit glutamate release |
Associated with schizophrenia in a Japanese case study (Takaki et al., 2004) |
| APBA2 amyloid beta (A4) precursor protein-binding, family A, member 2 (X11-like) GeneCards | Binds to NRXN1 ( see Entrez gene) | Duplication observed in a UK study Kirov et al, 2007 |
| NRXN1 Neurexin 1 GeneCards | regulates synapse formation Chubykin et al, 2005 Binds to APBA2 (see Entrez gene) | Deletion disrupting NRXN1 observed in a UK study Kirov et al, 2007 |
| Other genes whose products affect glutamate release or uptake | BDNF enhances depolarization-evoked glutamate release in cortical neurones (Balkowiec and Katz, 2002). Nicotinic CHRNA7 agonists stimulate glutamate release in the hippocampus and frontal cortex (Liu et al., 2003b;Marchi et al., 2002).CNR1 agonists inhibit glutamate release in a number of brain regions (Wang, 2003) (Gerdeman and Lovinger, 2001). GRM3, GRM4 and GRM8 receptor activation inhibits glutamate release (DD and Marek, 2002;Guo and Ikeda, 2005). HTR2A agonists stimulate frontal cortical glutamate release (Aghajanian and Marek, 1999), HTR6 receptor antagonism selectively increases glutamate release in the frontal cortex and hippocampus (Dawson et al., 2001). DRD2 receptor activation inhibits striatal and accumbens glutamate release (Bamford et al, 2004, Kalivas and Duffy, 1997)) HTR7 stimulation inhibits glutamate release in the dorsal raphe (Harsing, Jr. et al., 2004). IL1B and TNFA inhibit glutamate uptake into astrocytes and this effect is blocked by NO synthase inhibitors and mimicked by NO donors (Hu et al., 2000;Ye and Sontheimer, 1996). S100B stimulates glutamate uptake into astrocytes (Tramontina et al, 2006). NPY inhibits hippocampal glutamate release and blocks LTP(Whittaker et al., 1999). | |
| Genes coding for glutamate receptors and scaffold proteins, and related. | ||
| CIT Citron kinase | Binds to DISC1, GRIN1, GRIN2D | USA study Nicodemus et al, 2010 |
| GRIA1 AMPA
receptor subunit OMIM 138248 GeneCards |
AMPA receptor Binds to PICK1,GRIA4, HOMER1 |
Association reported in an Italian case study Magri et al, 2006 |
| GRIA3 glutamate receptor, ionotrophic, AMPA 3 GeneCards | AMPA receptor | Association restricted to females in an italian case study Magri et al, 2008 |
| AMPA receptor: Binds to PICK1 (Xia et al., 1999) and GRIA1 |
Association demonstrated in a Japanese case study(Makino et al., 2003). | |
| GRIK2 glutamate receptor, ionotropic, kainate 2 | Kainate receptor subunit | French study Bah et al, 2004 |
| GRIK3 Kainate receptor |
Kainate receptor subunit |
Association reported in an Italian case study (Begni et al., 2002). |
| GRIK4 Kainate receptor |
Kainate receptor subunit | Association with bipolar disorder and schizophrenia reported in a Scottish case study (Pickard et al., 2006) |
| GRID1 glutamate receptor, ionotropic, delta 1 GeneCards
|
Association
reported in Askenazi Jewish families (Fallin et al., 2005) |
|
| GOPC
golgi-associated PDZ and coiled-coil motif containing |
Binds to GRID1 and GRID2 | GWAS Moskvina et al, 2009 |
GRIN1 (NMDA receptor subunit NR1) OMIM 138249 GeneCards |
Binds to GRIN2A, GRIN2B, DLG2 |
Association reported in American, Chinese and Italian case studies (Begni et al., 2003;Martucci et al., 2003;Qin et al., 2005; Zhao et al, 2006). |
| Binds to GRIN1, DLG2 |
Association reported in two Japanese case studies (Itokawa et al., 2003b;Iwayama-Shigeno et al., 2005) | |
| Binds to GRIN1, DLG2 |
Association reported in Japanese Chinese and Italian case studies. (Di Maria et al., 2004;Miyatake et al., 2002;Ohtsuki et al., 2001)) | |
| Binds to GRIN1 |
Association reported in a Japanese case study (Makino et al., 2005) | |
| GRM5 Metabotropic glutamate receptor mgluR5 OMIM 604102 GeneCards |
GRM5 receptor activation potentiates both AMPA and NMDA receptor mediated responses (Ugolini et al., 1999) (Awad et al., 2000;Doherty et al., 2000) Interacts with RGS4 Schwenst and McGinty, 2007 |
Association in a British case study (Devon et al., 2001). Located at the Chromosome 11 breakpoint associated with schizophrenia (Semple et al., 2001) . |
| APC
adenomatous polyposis coli (colorectal tumor suppressor) OMIM 175100 GeneCards |
Binds to PSD-95 and GRIN2B and is a component of the NMDA receptor PSD-95 complex (Yanai et al, 2000) |
Association
in a Chinese family study(Cui
et al, 2005) |
| ARVCF armadillo repeat gene deleted in velocardiofacial syndrome OMIM 602269 GeneCards |
ARVCF binds to the PDZ domain of erbin (ERBB2IP) (Laura et al., 2002) a protein concentrated in postsynaptic membranes which binds to PSD-95 and to the NRG1 receptor ERBB2 (Huang et al., 2001) |
Possible association in a Chinese family study (Xie et al., 2005). |
ATXN1 (SCA1): ataxin 1) OMIM 601556 GeneCards |
Metabotropic mGluR1 (GRM1), NMDA-like (GRID1/GRID2) and AMPA receptor GRIA2/3 trafficking is altered in mutant ATXN1 transgenic mice (Skinner et al., 2001). Possible role in ubiquitin-proteasome and chaperone system Davidson et al, 2000 |
CAG repeats in this gene have been reported to associate with schizophrenia in American case (Joo et al., 1999)or family (Pujana et al., 1997)studies (Pujana et al., 1997).Association also reported in Ashkenazi Jewish families (Fallin et al., 2005) |
| DLG1 discs, large homolog 1 | Related to GRIN2A, GRIN2B, GRIA1, GRIK2 | Japanes study Sato et al, 2008 |
| DLG2 Chapsyn-110 |
Postsynaptic scaffold protein; Binds to GRIN1, GRIN2A, GRIN2B, NOS1 and NRG1 receptor ERBB4 |
DLG2 polymorphisms have not been reported in schizophrenia. However, PSZA11q14 is located in the first intron of and is antisense to DLG2 and has been suggested as a candidate gene for schizophrenia (Polesskaya et al., 2003). |
| DRPLA dentatorubral-pallidoluysian atrophy or atrophin-1 OMIM 607462 GeneCards |
Interacts with an insulin receptor tyrosine kinase substrate BAIAP2 (Okamura-Oho et al., 1999) which is localised in postsynaptic densities and binds to PSD-95 and DLG2 (Choi et al., 2005). |
Possible association of a CAG repeat in one family study(Morris-Rosendahl et al., 1997). |
| EFNB2 Ephrin B2 | Chinese study Zhang et al, 2010 | |
| Controls the localisation and clustering of Group 1 metabotropic glutamate receptors, GRM1 and GRM5 (Ango et al., 2000;Tadokoro et al., 1999). NMDA and GRM5 receptors are linked via HOMER and Shank (Tu et al., 1999). Gene ID 9456 |
Borderline association in a British case study (Norton et al., 2003). | |
| HOMER2 Homer hololog 2 | Regulates GRM1 GRIA1 and GRIK1 | Irish study Gilks et al, 2010 |
| LGI1 leucine-rich, glioma inactivated 1 OMIM 604619 GeneCards |
Binds to ADAM22 and potentiates AMPA responses in the hippocampus (Fukata et al, 2006 | Association reported in an Askenazi case-parent trio study(Fallin et al., 2005) |
| NPTN neuroplastin GeneCards | Inhibits hippocampal LTP by reducing the surface expression of AMPA receptors (Empson et al, 2006) | Saito
et al, 2006 |
| PICK1 protein kinase C alpha binding protein OMIM 605926 GeneCards |
Controls AMPA receptor clustering (Hanley and Henley, 2005) and binds to a number of AMPA receptor subunits including GRIA1 and GRIA4 (Xia et al., 1999).Also binds to the metabotropic receptor GRM3 (Hirbec et al., 2002) , the dopamine transporter SLC6A3 (Torres et al., 2001), NRG1 receptor ERBB2 (Jaulin-Bastard et al., 2001) and to serine racemase (SRR) an enzyme responsible for the synthesis of the NMDA co-agonist D-Serine (Fujii et al., 2005). Gene ID 2893 |
Association reported in Taiwanese and Japanese case studies (Fujii et al., 2005;Hong et al., 2004b). |
| RGS4 regulator of G-protein signalling 4 OMIM 602516 GeneCards |
Binds to NRG1 receptor ERBB3 (se Gene data). nhibits signaling via GRM1 and GRM5 (Saugstad et al, 1998) Transcription regulated by PHOX2B. Grillet et al, 2003 |
Suggested as a susceptibility gene in Indian family, Irish case, Israeli family, and Welsh case studies (Chowdari et al., 2002;Fallin et al., 2005;Morris et al., 2004;Williams et al., 2004b) |
| ZDHHC8 zinc finger, DHHC domain containing 8 OMIM 608784 GeneCards |
Localised to vesicle-like clusters along dendritic shafts occasionally colocalising with PSD-95 and the NMDA receptor subunit GRIN2B (Mukai et al., 2004). Gene ID 29801 |
Associated in American and Chinese case studies (Chen et al., 2004c;Mukai et al., 2004). |
| Altered PSD-95 expression and impaired glutamatergic signalling are observed in NPAS3 knockout mice (Brunskill et al., 2005). |
Situated in the breakpoint of a t(9;14)(q34;q13) translocation in a mother and daughter affected by schizophrenia (Kamnasaran et al., 2003). | |
| PPP1R1B protein phosphatase 1, regulatory (inhibitor) subunit 1B (dopamine and cAMP regulated phosphoprotein, DARPP-32) GeneCards | Dopamine D1 receptor simulation increases phosphorlation: Dephosphorylated by AMPA and NMDA receptor activation Nishi et al, 2002 |
Association observed in an american family-based study.Meyer-Lindenberg et al, 2007 |
Genes whose products affect NMDA receptor activation or elements of the postsynaptic scaffold Protein products associated with the postsynaptic density (Genes to Cognition) |
AKT1 is activated by NMDA receptor stimulation and phosphorylates NMDA receptors, potentiating their effects (Sanchez-Perez et al, 2006) . BDNF potentiates NMDA receptor mediated responses via a specific action at GRIN2B) (Levine and Kolb, 2000). In the cortex, BDNF stimulates the expression of AMPA receptors and maintains their elevated activity (Balkowiec and Katz, 2002;Nagano et al., 2003). BDNF increases the expression of a number of PDZ domain proteins, including DLG1, GRIP1 and PICK1 in cortical culture (Jourdi et al., 2003). DISC1 binds to elements of the postsynaptic glutamate receptor scaffold (AKAP9, ACTN2, GRIPAP1, HAPIP, SPTAN1) (Millar et al., 2003). GRM5 receptor activation potentiates both AMPA and NMDA receptor mediated responses (Ugolini et al., 1999) (Awad et al., 2000). NRG1 inhibits NMDA receptor mediated responses in the prefrontal cortex and increases the internalisation of the NR1 subunit (GRIN1) of the NMDA receptor (Gu et al., 2005). PAX6 binds to elements of the postsnaptic scaffold (Cooper and Hanson, 2005) Dopamine can both potentiate and inhibit NMDA responses in the frontal cortex. The stimulatory effects are mediated by DRD1/DRD5 receptor activation (Wirkner et al., 2004) via a direct coupling of DRD1 to GRIN1 and GRIN2A (Lee et al., 2002). DRD2 and DRD4 agonists repress NMDA responses in the hippocampus via transactivation of the platelet derived growth factor receptor PDGFRA (Kotecha et al., 2002) (Ferguson, 2003) and DRD4 agonists inhibit NMDA effects in prefrontal cortex (Wang et al., 2003). EGF enhances NMDA receptor mediated responses in the hippocampus (Abe and Saito, 1992) and facilitates hippocampal LTP (Abe et al., 1991;Ishiyama et al., 1991). IL1B inhibits NMDA receptor mediated synaptic responses in the rat dentate gyrus (Coogan and O'Connor, 1997). |
|
| Table 4: Genes coding for downstream signalling effectors and related | ||
| HMBS Hydroxymethylbilane synthase (Invoved in heme synthesis) OMIM 609806 GeneCards |
NOS1 (Boehning and Snyder, 2003) and PTGS2 (Percival et al., 1994) are heme dependent enzymes. HMBS is part of the heme synthesis pathway. |
Association reported in an American case study (Sanders et al., 1993) |
| NOS1Nitric oxide synthase |
Stimulated by NMDA receptor activation via PSD95 (DLG4 Gene ID 1742) which associates with NMDA and NRG1 receptors ERBB2 and ERBB4: Binds to DLG2 and CAPON: |
Association described in Japanese and German case studies and in Askenazi Jewish families (Shinkai et al., 2002) (Fallin et al., 2005) (Reif et al., 2006). GWAS Moskvina et al, 2009 |
| PLA2G4Aphospholipase A2, group IVA (Cytosolic, calcium-dependent) |
Cytosolic Phospholipase A2 activity is stimulated by the free radical derivative of nitric oxide and superoxide, peroxynitrite (Guidarelli et al., 2000;Tommasini et al., 2002) and by NMDA receptor activation in the striatum (L'hirondel et al., 1999). |
Associated in American case and family, British family and Chinese family studies(Hudson et al., 1996;Tao et al., 2005b;Wei and Hemmings, 2004a;Yu et al., 2005) . |
| Associated in a Chinese family (Tao et al., 2005a) | ||
| Associated in a Chinese family study (Tao et al., 2005a) | ||
| PLA2G6 phospholipase A2, group VI (cytosolic, calcium-independent) | Brazilian study Junquiera et al, 2004 | |
PPP3CC Calcineurin A gammaOMIM 114107 GeneCards |
NMDA receptor activation stimulates NOS1 activity via calcineurin dephosphorylation of the enzyme. |
Association in an American family study (Gerber et al., 2003) |
| PTGS2 Cyclooxygenase-2 |
Activity and expression are increased by NMDA receptor activation (Adams et al., 1996) (Pepicelli et al., 2002) Binds to TP53 |
Associated with schizophrenia in a British family study (Wei and Hemmings, 2004a) |
| SOD2 activity is inhibited by NMDA receptor activation via nitration releasing superoxide into the extracellular space (Muscoli et al., 2004). Binds to TP53 (Zhao et al, 2005) |
Association reported in a Turkish case study (Akyol et al., 2005). | |
| Genes involved in neuritogenesis and plasticity | ||
| ALK (anaplastic lymphoma kinase) pleiotrophin receptor OMIM 105590 GeneCards | Promotes neurite outgrowth (Motegi et al, 2004). |
Association in a Japanese case study Kunugi et al, 2006 |
| CHN2 is induced by BDNF and its overexpression in cerebellar neurones prevents the inhibitory effects of myelin-associated glycoprotein (MAG) on neurite extension (Mizuno et al., 2004). |
Associated with schizophrenia inmale Japanese cases (Hashimoto et al., 2005). | |
DPYSL2 dihydropyrimidinase-like 2 OMIM 602463 GeneCards |
A member of the collapsin response mediator protein family involved in neuronal development and axon guidance (Charrier et al., 2003;Quach et al., 2004a). NMDA receptor activation results in increased calpain cleavage of DPYSL2 and the resulting product reduces the surface expression of the NMDA receptor subunit GRIN2B (Bretin et al, 2006) Binds to DISC1 (Camargo et al, 2006) |
Polymorphisms in DPYSL2 have been suggested to reduce susceptibility to schizophrenia in a Japanese case study(Nakata et al., 2003). Also associated with schizophrenia in an Askenazi Jewish family study (Fallin et al., 2005) and in Caucasian and African Americans (Case study) (Hong et al., 2005) |
|
Disrupted in schizophrenia 1 |
Involved
in neurite outgrowth and cortical development. Binds to other SZ
gene products CIT, FEZ1, PCNT, PDE4B, MLC1,MYT1L, NDEL
, NDE1 TRAF3IP1 and to a number of proteins associated with the
glutamatergic receptor scaffold (ACTN2
,AKAP9
,
SPTAN1) as well as to DPYSL2 Camargo
et al, 2006 |
DISC1 and DISC2, a non-coding sequence antisense to DISC1 are within a chromosomal translocation associated with schizophrenia and psychosis in a Scottish family (Millar et al., 2000). Subsequent American, Finnish and Scottish case studies have confirmed an association of DISC1 with schizophrenia (Blackwood and Muir, 2004;Callicott et al., 2005;Cannon et al., 2005;Hennah et al., 2003;Hodgkinson et al., 2004;Millar et al., 2001;Sachs et al., 2005;Zhang et al., 2006). MAJOR HUB GENE |
| Binds to DISC1: Role in neurite development and axonal outgrowth: Binds to BRD1 (Assmann et al, 2006) |
Association in a Japanese case study (Yamada et al., 2004b) | |
| KIF2A kinesin heavy chain member 2A OMIM 602951 GeneCards |
Involved in BDNF-mediated neurite extension (Pfenninger et al, 2003) | Association reported
in a chinese family study (Li et al, 2006) |
| NDE1 LIS1-interacting protein NUDE1GeneCards | Binds to DISC1 | Female-specific association in Finnish familiesHennah et al, 2006 |
| NDEL1 nudE nuclear distribution gene E homolog (A. nidulans)-like 1 GeneCards | Thiol-activated peptidase (EOPA).Role in microtubule organisation and cell migration. Binds to DISC1 | DISC1-dependent association in an American study Burdick et al, 2008 |
| Promotes neurite extension in thalamic and cortical neurones (Nakashiba et al., 2002) |
Associated with schizophrenia in case and family based Japanese studies (Aoki-Suzuki et al., 2005;Fukasawa et al., 2004) | |
| Promotes neurite extension in thalamic and cortical neurones (Nakashiba et al., 2002) |
Associated with schizophrenia in a Japanese family study (Aoki-Suzuki et al., 2005) | |
| Semaphorin receptor involved in axon guidance |
Associated with schizophrenia in an american case study (Mah et al., 2006) | |
| PNOC Prepronociceptin GeneCards | Precursor for nocipeptin/orphanin. Induced by BDNF in thehippocampus and plays a role in neurite outgrowth Ring et al, 2006 | Association reported in an Askenazi case-parent trio study Fallin et al., 2005) |
| Potent neurite outgrowth inhibitor acting via RTN4R |
A CAA insertion observed in schizophrenia is in the 3' untranslated region of the gene (Novak et al., 2002). Also associated with schizophrenia in females but not males in a Singaporean case study (Tan et al., 2005). . | |
RTN4R Reticulon 4 receptor OMIM 605566 GeneCards |
RTN4 receptor that also binds to MAG. |
Mutations in the RTN4R receptor were found in 3/120 schizophrenic patients and in 0/300 normal subjects. Two of the schizophrenic patients with a missense mutation were resistant to neuroleptic treatment (Sinibaldi et al., 2004). |
| Other genes controlling neurite/ dendrite morphology | APOE (Qiu et al., 2004), BDNF (Alonso et al., 2004),CHL1 (Demyanenko et al., 2004), CHN2 (Mizuno et al., 2004),CNR1 (Zhou and Song, 2001), DISC1 (Miyoshi et al., 2003), DPYSL2 (Quach et al., 2004b), EGF (Mark et al., 1995), FEZ1 (Miyoshi et al., 2003), HOMER (Sala et al., 2001),IL1B (Gilmore et al., 2004),IL2 (Jiang and Lu, 1998), LTP and NMDA receptor activation (GRIN1, GRIN2A, GRIN2B, GRIN2D)(Collin et al., 1997) , MAG (Domeniconi et al., 2002), NPAS3 (Pieper et al., 2005), NRG1 (Gerecke et al., 2004), NTF3 (Baker et al., 1998), RTN4 and RTN4R, TNFA (Gilmore et al., 2004) | |
| Table 6: Growth factors, tyrosine kinase receptors, phoshoinositide kinase/AKT signaling | ||
AKT1 v-akt murine thymoma viral oncogene homolog 1OMIM 164730 |
Growth factor signalling. The AKT1 pathway is also activated by NMDA receptor stimulation and AKT1 phosphorylates NMDA receptors , potentiating their effects (Sanchez-Perez et al., 2006). |
Reported as a schizophrenia susceptibility gene in American and Japanese case and Australian family studies (Emamian et al., 2004) (Ikeda et al., 2004;Schwab et al., 2005). |
| GSK3B glycogen synthase kinase 3 beta GeneCards | Serine threonine kinase involved in multiple signaling networks | Association in a Brazilian Case control study Souza et al, 2008 |
BDNFbrain derived neurotrophic factor |
BDNF release is stimulated by NMDA receptor activation in the hippocampus (Jiang et al., 2005).BDNF enhances depolarization-evoked glutamate release in cortical neurones (Balkowiec and Katz, 2002).BDNF potentiates NMDA receptor mediated responses via a specific action at GRIN2B) (Levine and Kolb, 2000). In the cortex, BDNF stimulates the expression of AMPA receptors and maintains their elevated activity (Balkowiec and Katz, 2002;Nagano et al., 2003). BDNF increases the expression of a number of PDZ domain proteins, including DLG1, GRIP1 and PICK1 in cortical culture (Jourdi et al., 2003). Enhances phosphorylation of GRIN1 (Suen et al, 1997) GRIN2B (Lin et al, 1998) and GRIA1 (Wu et al, 2004). BDNF increases SLC1A2 expression in astrocytes (Rodriguez-kern et al, 2003) |
Reported association in American case and family, French, Hungarian and Scottish case and Spanish family studies .(Fanous et al., 2004b;Krebs et al., 2000a;Krebs et al., 2000b;Muglia et al., 2003;Neves-Pereira et al., 2005;Rosa et al., 2006;Szekeres et al., 2003) |
| BMP6 bone morphogenetic protein 6 | Taiwan study Lin et al, 2009 | |
CNTF ciliary neurotrophic factor OMIM 118945 GeneCards |
Growth factor: Potent survival factor for neurones astrocytes and oligodendrocytes; Promotes neurite extension. OLIG2 nuclear export in astrocytes is induced by CNTF via phosphorylation of OLIG2 by AKT1 (Setoguchi and Kondo 2004) Binds to APOE |
Null mutation (Lin and Tsai, 2004;Thome et al., 1996) |
| DDR1 discoidin domain receptor family, member 1 GeneCards | Tyrosine kinase expressed in oligodendrocytes and activated by collagens Franco-Pons et al, 2006 | Association reported in a Spanish case study Roig et al, 2007 |
| DGKI diacylglycerol kinase, iota | Final step of PI3 kinase pathway: Phosphotylates diacylglycerol to phosphatidic acid | GWAS Moskvina et al, 2009 |
| EFNB2 Ephrin B2 | Tyrosine kinase | Association in a Chinese study Zhang et al, 2010 |
EGF Epidermal growth factor OMIM 131530 GeneCards |
NRG1 inhibits EGF binding to either EGFR or the Neuregulin receptor ERBB2. Increases expression of SLC1A2 in astrocytes (Zelenaia et al, 2000) |
Associated in a Finnish case study (Anttila et al., 2004). In one case study the association was conditional on a concurrent TNFA polymorphism (Kampman et al., 2005) In another case study association was only reported in men (Hanninen et al., 2005a) . |
| EGFR EGF receptor GeneCards | EGF/ NRG1, ERBB2, ERBB3 interact | Benzel et al, 2007 |
| EGR2 early growth response 2 (Krox-20 homolog, Drosophila) GeneCards | Important role in peripheral myelination: Upregulated by NMDA receptor activation during hippocampal long-term potentiation Inokuchi et al, 1996 | Yamada et al, 2007 |
| EGR3 early growth response 3 GeneCards | Synthesis indiced by BDNF in hippocampus Roberts et al, 2006 by NMDA receptor activation Yamagata et al, 1994 and by NRG1 in muscle Jacobson et al, 2004 | Yamada et al, 2007 |
| EGR4 early growth response 4 GeneCards | Yamada et al, 2007 | |
| FGF1 fibroblast growth factor 1 (acidic) GeneCards | Plays a role in oligodendrocyte myelination (inter alia) Harari et al, 1997 | Weak association in a Dutch case-control studyJungerius et al, 2007 |
| FGF14 Fibroblast growth factor 14 | Jungerius eyt al, 2007 | |
| FGF18 Fibroblast growth factor 18 | Binds to FGFR1, 2, 3 and 4 | Jungerius eyt al, 2007 |
| FGFR1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) GeneCards | FGF1 and FGF2 receptor | Weak association in a Dutch case-control studyJungerius et al, 2007 |
| FYN FYN oncogene related to SRC, FGR, YES GeneCards | Associated with BDNF receptor signalling (NTRK2) Iwasaki et al, 1998. Associates with GRIN2A and GRIN2B Takagi et al, 1999 BDNF enhances NMDA currents via FYN Xu et al, 2006. Involved in NCAM1 signalling Beggs et al, 1997 |
Rybakowski et al, 2007 |
| GDNF Glial derived neurotrophic factor GeneCards | Ligand for GFRA1 and 2 | Association reported in an Italian study Michelato et al, 2004 |
| GFRA1 GDNF family receptor alpha 1GeneCards |
GDNF and neurturin receptor. Possible involvement in oligodendrocyte development (Strelau and Unsicker 1999). Expression regulated by TNF in glial cells (Remy et al, 2003). Involved in the development and migration of cortical GABA neurones (Pozas and Ibanez,2005) | Association reported
in an Ashkenazi Jewish case-parent trio study (Fallin et al., 2005). |
| GFRA2 GDNF family receptor alpha 2 | GDNF and neurturin receptor | Canadian study Souza et al, 2010 |
| GFRA3 GDNF family receptor alpha 3 | Artemin receptor | Canadian study Souza et al, 2010 |
| IGF2 insulin-like growth factor 2 (somatomedin A) | Croatian study Pal et al, 2009 | |
| LIF leukemia inhibitory factor (cholinergic differentiation factor) | Japanese study Okahisa et al, 2010 | |
| METmet proto-oncogene (hepatocyte growth factor receptor) | USA study Burdick et al, 2010 | |
| NEUROG1 Neurogenin 1 | US study Fanous et al, 2007 | |
| Glial growth factor: NRG1 inhibits NMDA receptor mediated responses in the prefrontal cortex and increases the internalisation of GRIN1 (Gu et al., 2005). NRG1 receptor ERBB2, binds to the AMPA receptor clustering protein PICK1 (Jaulin-Bastard et al., 2001). A cleaved intracellular domain of NRG1 translocates to the nucleus binds to the PSD-95 (DLG4) promoter (Bao et al, 2004) |
Association reported in Chinese, Icelandic, Portugese, Scottish and Welsh populations (Li et al., 2004b;Norton et al., 2005;Petryshen et al., 2005;Stefansson et al., 2002;Stefansson et al., 2003;Tang et al., 2003a;Williams et al., 2003b;Yang et al., 2003b).(Case and family studies). | |
| NRG2 Neuregulin 2 GeneCards | Binds to ERBB3 and ERBB4 | Benzel et al, 2007 |
| NRG3 Neuregulin 3 GeneCards | Oligodendrocyte growth factor (Carteron et al, 2006): Binds to ERBB4 | Association reported
in an Ashkenazi Jewish case-parent trio study (Fallin et al., 2005). |
| ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog GeneCards | Heterodimerises with EGFR or ERBB3 | Benzel et al, 2007 |
| ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 | Neuregulin receptor interacting with EGFR and ERBB2 | Chinese study Li et al, 2009 |
| Binds to NRG1 , DLG2 and PSD-95 (DLG4) . NRG1 induces the expression of NOS1 in cerebellar granule cells via ERBB4 (Krainock and Murphy, 2001b). A cleaved intracellular domain of ERBB4 phosphorylates the p53 activator MDM2 and increases TP53 levels in peripheral cells (Arasada and Carpenter 2005) |
Interaction between NRG1 and ERBB4 in a UK casestudy (Norton et al., 2005). Association also reported in an Israeli case study(Silberberg et al., 2006). | |
| IMPA2 inositol(myo)-1(or 4)-monophosphatase 2 OMIM 605922 GeneCards |
PI signalling and inositol phosphate metabolism |
IMPA2 associates with schizophrenia in a Japanese case study (Yoshikawa et al., 2001). |
| JARID2 jumonji, AT rich interactive domain 2 OMIM GeneCards | Negative regulation of cell growth Toyoda et al, 2000 | Pedrosa et al,2006 |
| NRN1 Neuritin 1 | Australian study Chandler et al, 2010 | |
| Neurotrophin; Ligand for NTRK3: Promotes oligodendrocyte survival |
NTF3 polymorphisms associating with schizophrenia have been reported in Japanese case studies (Hattori and Nanko, 1995;Nanko et al., 1994) and in male schizophrenics in England (case study) (Dawson et al., 1995). A metaanalysis combining case results from Caucasian patients with a Swedish study provided support for an association between NTF3 and schizophrenia (Jonsson et al., 1997). | |
| NTRK3 neurotrophic tyrosine kinase, receptor, type 3 | Receptor for NTF3 | GWAS European ancestry Shi et al, 2009 |
| PDGFRB platelet-derived growth factor receptor, beta polypeptide GeneCards | Binds to EGFR and FYN | Association in a Korean study Kim et al, 2008 |
| PIK3C2G phosphoinositide-3-kinase, class 2, gamma polypeptide GeneCards | PI3 kinase: Not fully characterised | Weak association in a Dutch case-control studyJungerius et al, 2007 |
| PIK3C3 phosphoinositide-3-kinase, class 3 OMIM 602609 GeneCards |
Converts Phosphatidylinositol to Phosphatidylinositol 3 phosphate (Volinia et al. 1995) Involved in EGF receptor endocytosis (Zheleznova et al, 2003) | A promoter variant of PIK3C3 is associated with bipolar disorder and schizophrenia in case studies(Stopkova et al., 2004). Also associated in a family based chinese study (Duan et al 2005) |
| PI4KA phosphatidylinositol 4-kinase, catalytic, alpha GeneCards | Catalyzes the first step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate | Association in a Dutch case-control studyJungerius et al, 2007 |
| PIK42B phosphatidylinositol 4-kinase type 2 beta | Scottish study Houlihan et al, 2009 | |
| PI4KA phosphatidylinositol 4-kinase, catalytic, alpha (PIK4CA) | Synthesis of phosphatidylinositol 4,5-bisphosphate | Dutch study Jungerius et al, 2007 |
| PIP4K2A phosphatidylinositol-5-phosphate 4-kinase, type II, alpha | Irish study Thistleton et al, 2010 | |
|
phosphatidylinositol-4-phosphate 5-kinase, type II, alpha OMIM 603140 GeneCards |
Metabolises Phosphatidylinositol 3 phosphate to phosphatidylinositol 3,4-biphosphate and phosphatidylinositol 3,4,5-triphosphate (Zhang et al. 1997). Also metabolises phosphatidylinositol-4-phosphate, and phosphatidylinositol-5-phosphate (Rameh et al. 1997) (products of phosphatidylinositol 4- and 5-kinases to phosphatidylinositol-4,5-bisphosphate (Loijens et al. 1996) and is thus capable of generating multiple second messengers.Phosphatidylinositol 3,4,5-triphosphate inhibits the GTPase activating effects of RGS4 Ishii et al,2002 |
Associated with both bipolar disorder and schizophrenia in case studies (Stopkova et al., 2003). |
| PLCB1 phospholipase C, beta 1 (phosphoinositide-specific) | catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate | GWAS Moskvina et al, 2009 |
| PTPRZ1 protein tyrosine phosphatase, receptor-type, Z polypeptide 1 OMIM GeneCards | Involved in NRG1/ERBB4 signaling Buxbaum et al, 2007 Activates ALK Perez-Pinera et al, 2007 and FYN Pariser et al, 2005 LTP enhanced in knockout miceNiisato et al, 2005 | UK case studyBuxbaum et al, 2007 |
| SEMA3D Semaphorin 3D | Japanese study Fuji et al, 2010 | |
| SPRY4 sprouty homolog 4 GeneCards | Negative regulator of FGF signaling and of the MAPK pathway | Association in UK trios Zaharieva et al, 2008 |
| WDFY2 WD repeat and FYVE domain containing 2 | Binds to AKT1 | GWAS Moskvina et al, 2009 |
| Oligodendrocyte related genes | ||
| ARHGEF10 Rho guanine nucleotide exchange factor (GEF) 10 GeneCards | Role in myelination of peripheral nerves | Weak association in a Dutch case-control studyJungerius et al, 2007 |
CNP 2',3'-cyclic nucleotide 3' phosphodiesterase OMIM 123830 GeneCards |
Almost exclusively localised in myelin containing cells |
Described as a susceptibility gene in a UK case study (Peirce et al., 2006) |
| GNPAT glyceronephosphate O-acyltransferase |
Involved in the synthesis of plasmalogens which are important constrituents of myelin. Abnormal myelinisation is observed in GNPAT deficiency (Szrriha et al, 1997)
|
Polymorphism reported in Taiwan (Lin et al, 2006) |
MAG myelin-associated glycoprotein OMIM 159460 GeneCards |
Mediates
myelin-neuron cell-cell interactions; Inhibits neurite extension via
RTN4R |
Polymorphism associated with schizophrenia in a chinese family study (Wan et al., 2005) |
MOG myelin oligodendrocyte glycoprotein OMIM 159465 GeneCards |
May be involved in completion and maintenance of the myelin sheath and in cell-cell communication. Recognised by HLA-DRB1. |
Associated with schizophrenia in a Chinese family study (Liu et al., 2005b). |
| CSPG5 Neuroglycan C | Midkine receptor: Promotes oligodedrocyte growth Ishihara_tanaka et al, 2006 | Chinese study So et al, 2010 |
| MYT1L myelin transcription factor 1-like | Binds to DISC1 | Copy number variation Vrijenhioek et al, 2008 |
| NOTCH signalling in general plays an important role in oligodendrocyte development (Park and Appel, 2003;Popko, 2003) but the role of NOTCH4 has not been specifically examined.Ckeaved by PSEN2 |
Association reported in African American case and family, Indian family and Chinese mixed pedigree studies (Luo et al., 2004;Prasad et al., 2004;Skol et al., 2003;Wang et al., 2005). Japanese and Chinese studies suggest association only in subsets of early onset patients and/or with negative symptoms (Takahashi et al., 2003) and in a GWAS study Stefanssonnet al, 2009. | |
| OLIG2
oligodendrocyte lineage transcription factor 2 OMIM 606386 GeneCards |
Key transcription factor in oligodendrocyte development (Ligon et al, 2006). Inhibits astrocyte differentiation and reactive astrocytosis (Cassiani-Ingoni et a, 2006). Transport from nucleus to cytoplasm may be needed in relation to inhibitory effects on astrocyte differentiation.This export is induced by CNTF via phosphorylation of OLIG2 by AKT1 (Setoguchi and Kondo 2004). See also PAX6 and PHOX2B interactions with OLIG2 in development | Association reported
in a UK case study Georgieva et al, 2006 |
| PAX6paired box gene 6 (aniridia, keratitis) OMIM 607108 GeneCards |
Regulates oligodendrocyte development and NRG1 expression (Assimacopoulos et al., 2003;Sun et al., 1998). Binds to HOMER3 ( a partner of GRM5), DYNLL1 (a NOS1 inhibitor) and TRIM11 (Cooper and Hanson 2005) and SHANK3 |
Promoter polymorphism associates with schizophrenia in a German case study (Stober et al., 1999). |
| Proteolipid protein with role in myelinisation. Coimmunoprecipitates with MAG and MBP. Arvanitis et al, 2002 |
Weak association in males in a family-based chinese study (Qin et al., 2005c) | |
| PSAP Prosaposin GeneCards | Myelinotrophic factor | Weak association in a Dutch case-control studyJungerius et al, 2007 |
| SOX10 SRY (sex determining region Y)-box 10 OMIM GeneCards | Transcription factor with a key role in oligodendrocyte development. Targets include CNTF Ito et al, 2006, ERBB3 Britsch et al, 2001, MBP Wei et al, 2004 TYR Murisier et al, 2007. Regulated by QK1 Aberg et al, 2006 | Associated in a Japanese study Maeno et al, 2007 |
| TF Transferrin GeneCards | Iron transport: Important role in oligodendrocyte function Connor and Menzies, 1996 | Association in the Chinese Han population Qu et al, 2007 |
| Required for oligodendrocyte differentiation and myelinisation in mice. Controls the messenger RNA translation or splicing of both myelin basic protein and MAG (Ryder and Williamson, 2004;Wu et al., 2002) Regulates PLP1, MAG, MBP, TF, SOX10, and CDKN1BAberg et al, 2006. Binds to PTPB2 Lim et al, 2006 |
Associated with schizophrenia in Swedish family-based study (Aberg et al., 2005) | |
| Genes whose products kill oligodendrocytes |
AMPA (Yoshioka et al., 1995), kainate (Sanchez-Gomez and Matute, 1999) and NMDA (Salter and Fern, 2005) receptor activation (cf GRIA4, GRIK3. GRIN1, 2A,2B,2D), dopamine (Khorchid et al., 2002), IL1B (Takahashi et al., 2003a) , LTA)(Plo et al., 1999), Lysophosphatidylcholine (Fressinaud and Vallat, 1994) a product of PLA2G4, Nitric oxide (Rosenberg et al., 1999) or peroxynitrite (Mitrovic et al., 1996;Scott et al., 2003) products of NOS1, TGF beta (Schuster et al., 2002;Schuster et al., 2003), which signals via PCQAP (Kato et al., 2002) TNFA (D'Souza et al., 1996), TP53 (Eizenberg et al., 1995). | |
| Genes whose products protect oligodendrocytes or are involved in their development |
CNR1 agonists (Molina-Holgado et al., 2002), CNTF DRD2 and DRD3 receptor activation (Rosin et al., 2005).GRM5 receptor agonists (Deng et al., 2004a). Inhibition of the PI3 kinase cell survival pathway produces apoptosis in oligodendrocytes (Vemuri and McMorris, 1996) (cf AKT1 , PIK3C3, PIP5K2A). BDNF, (Du et al., 2003), NOTCH signalling (Park and Appel, 2003) (cf NOTCH4 ), NTF3 (Barres et al., 1994;Heinrich et al., 1999;Kumar et al., 1998), NRG1 (Calaora et al., 2001;Fernandez et al., 2000;Flores et al., 2000), PAX6 (Sun et al., 1998), IL2 (Jiang and Lu, 1998), IL10 (Molina-Holgado et al., 2001) S100B (Deloulme et al., 2004). Glutathione (cf SLC1A2, GSTM1) protects against diverse toxic insults(Liu et al., 2002b) (Khorchid et al., 2002;Lee et al., 2004) (Richter-Landsberg and Vollgraf, 1998). Nitric oxide (NOS1) protects oligodendrocytes in conditions of thiol depletion (Rosenberg et al., 1999). | |
| Dopaminergic system genes | ||
| ALDH3B1 Aldehyde dehydrogenase 3 family, member B1 OMIM 600466 GeneCards |
Multiple substrates include catecholamine metabolites. |
Association in Chinese case studies (Sun et al., 2005b;Xu et al., 2004): |
| Methylates catecholamines and catecholamine derived quinones (Zhu, 2004). COMT activation also increases the synthesis and release of homocysteine from astrocytes (Huang et al, 2005) (related to S-adenosylmethionine metabolism) |
A meta-analysis of case and family based data suggested a stronger effect in patients of European ancestry (Glatt et al., 2003a). See (Munafo et al., 2005) for conflicting conclusion. | |
| CHGA Chromogranin A GeneCards | Role in tranmitter/hormone secretion in neural and endocrine cells | Association in a Japanese case-control Takahashi et al, 2006 |
| Plays a role in dopamine storage. |
Suggested as a susceptibility gene in Japanese and Chinese case studies (Kitao et al., 2000) (Zhang et al., 2002) | |
| DBH Dopamine beta hydroxylase | Cinverts dopamine to noradrenaline | Croatian study Pal et al, 2009 |
| Binds to PICK1 and STX1A |
Reported association in American case and family and Chinese case studies (Blum et al., 1997;Fanous et al., 2004a;Zhang et al., 2003) | |
| Target of most neuroleptics: Dysbindin or MUTED knockdown blocks D2 dopamine receptor (DRD2) internalisation, increasing cell surface expression Iizuka et al, 2007. Agonists attenuate oligodendrocyte damage induced by glutamate or oxidative stress Roisin et al, 2005 |
Significant association in a meta-analysis of 24 case studies (Glatt et al., 2003b) | |
| Agonists attenuate oligodendrocyte damage induced by glutamate or oxidative stress Roisin et al, 2005 |
Significant association reported in a meta-analysis of over 30 case studies (Williams et al., 1998) | |
| No overall association in a meta-analysis of 19 worldwide independent samples but significant association reported in Caucasian subjects especialy in family studies (Lung et al., 2002;Williams et al., 1998) | ||
| Association in two British case studies (Williams et al., 1997) (Muir et al., 2001) | ||
| KCNN3 small conductance calcium-activated potassium channel, (Alias KCa2.3, SK3, SKCA3, hSK3) OMIM 602983 GeneCards |
Controls the firing rate of dopaminergic neurones in the substantia nigra (Wolfart et al., 2001) |
Associated with schizophrenia in Israeli ,Indian, Serbian and Taiwanese case studies (Dror et al., 1999;Ivkovic et al., 2006;Ritsner et al., 2002;Saleem et al., 2000;Tsai et al., 1999a) |
|
Oxidises monoamines, generating hydrogen peroxide RCH2NH2 + H2O + O2 = RCHO + NH3 + H2O2 |
Association reported in British and Swedish case studies (Jonsson et al., 2003;Wei and Hemmings, 1999). | |
| MAOB monoamine oxidase B | Spanish study Carrera et al, 2008 | |
| RNLS FAD-dependent amine oxidase (c10orf59)MAOC | Metabolises catecholamines Luft, 2005 | GWAS African American Shi et al, 2009 |
| NCKAP5 NCK-associated protein 5 | Partner binds to dopamine receptors | GWAS Wang et al, 2010 |
| L-phenylalanine
+ tetrahydrobiopterin + O2 = L-tyrosine + |
Weak association reported in an American sib-pair study (Wilcox et al., 2002). | |
| SLC18A1 solute carrier family 18 (vesicular monoamine), member 1 GeneCards | Dopamine, noradrenaline and serotonin vesicular uptake | Association reported in a Japanese study Richards et al, 2006 |
| SLC18A2 solute carrier family 18 (vesicular monoamine), member 2 GeneCards | Association reported in a spanish studyGutierrez et al, 2007 | |
TH Tyrosine hydroxylase OMIM 191290 GeneCards |
L-tyrosine
+ tetrahydrobiopterin + O2 = |
Association reported in French, Japanese , Korean and Welsh case studies (Kurumaji et al., 2001;Meloni et al., 1995;Pae et al., 2003b;Thibaut et al., 1997;Wei et al., 1995) |
| Regulates dopamine release |
Association reported in Japanese and Spanish case studies and weak (Tachikawa et al., 2000;Wang et al., 2002;Zhang et al., 2000) association reported in an America case study (Sanjuan et al., 2004) | |
Glutathione, quinone and oxidative stress related genes For an interesting history on quinones and schizophrenia see Smythies 1997 . |
||
| GCLC glutamate-cysteine ligase, catalytic subunit GeneCards | First rate limiting enzyme of glutathione synthesis. Expression controlled by NFE2L2, binding partner of ATF4 (see DISC1, GABBR1): Glutathione depletion impairs synaptic plasticity (LTP) and reduces NMDA receptor-mediated effects Steullet et al, 2006 | Association reported in a Swiss study Gysin et al, 2007 |
| GCLM
glutamate-cysteine ligase, modifier subunit OMIM 600176 GeneCards |
First rate limiting enzyme of glutathione synthesis. Expression controlled by NFE2L2, binding partner of ATF4 (see DISC1, GABBR1) | Association reported
in two case and one family study Tosic et al, 2006 |
| GSS Glutathione synthase | ATP-dependent conversion of gamma-L-glutamyl-L-cysteine to glutathione | Swiss Study Tosic et al, 2006 |
GSTM1 Glutathione transferase M1 OMIM 138350 GeneCards |
Cyclised quinones formed from dopamine or other catecholamines are conjugated by glutathione, a reaction catalysed principally by the mu class of glutathione transferases (Baez et al., 1997) including GSTM1. Expression controlled by NFE2L2, binding partner of ATF4 (see DISC1, GABBR1) |
A GSTM1 deletion has been associated with schizophrenia in Japanese and Korean case studies (Harada et al., 2001;Pae et al., 2004). |
| GSTT1 glutathione S-transferase theta 1 GeneCards | Saadat et al, 2007 | |
| Potent antioxidant: Binds to hemoglobin preventing induction of oxidative stress. | Association reported in a Chinese study Wan et al, 2007 | |
MDR1/ABCB1 P-glycoprotein 1 OMIM GeneCards |
Involved in NO-related glutathione efflux Watts et al, 2006
|
Association reported in a female Croatian case-study Bozina et al, 2006 GWAS Moskvina et al, 2009 |
| ME2 malic enzyme 2, NAD(+)-dependent, mitochondrial GeneCards | Plays an important role in regenerating reduced glutathione Vogel et al, 1999 |
Lee et al, 2007 (psychosis and mania) |
| MSRA Methionine sulfoxide reductase GeneCards | Converts methionine sulfoxide to methionine: Possible role in repairing damage to oxidised proteins | Costa Rica Family study Walss-Bass et al, 2008 |
NQO2 NAD(P)H dehydrogenase, quinone 2 OMIM 160998 GeneCards |
Quinone reductases play a role in eliminating dopamine-derived quinones (Graumann et al., 2002).Expression controlled by NFE2L2, binding partner of ATF4 (see DISC1, GABBR1) |
A deletion in the promoter region of the NQO2 gene is associated with schizophrenia in a Japanese case study (Harada et al., 2003). |
S100B Catecholase |
Converts DOPA to dopachrome, adrenaline to adrenochrome and noradrenaline to noradrenachrome (Senior et al., 2003). Role in neurite extension and astrocytosis and oligodendrocyte development (Deloulme et al., 2004) Binds to TP53 |
Associated with schizophrenia in a Chinese case study (Liu et al., 2005a) |
| SOD2 Manganese-dependent superoxide dismutase OMIM 147460 GeneCards |
2 superoxide + 2 H(+) <=> O2 + H2O2 Binds to TP53 in mitochondria (Zhao et al, 2005) |
Association reported in a Turkish case study (Akyol et al., 2005). |
| L-tyrosine + L-dopa + O(2) <=> L-dopa + dopaquinone + H(2)O. Expression controlled by TP53 (Khlgatian et al, 2002) |
Schizophrenia has been linked to a chromosomal translocation at (1:11)(q42.1, q14.3). Genes within the chromosome 11 breakpoint include GRM5, NAALADase II and TYR (Petit et al., 1999;Semple et al., 2001). | |
TP53 tumor protein p53 OMIM 191170 GeneCards |
Numerous binding partners including PTGS2, SOD2 and S100B. Controls TYR expression (Khlgatian et al, 2002). A cleaved intracellular domain of ERBB4 phosphorylates the p53 activator MDM2 and increases TP53 levels in peripheral cells (Arasada and Carpenter 2005) . Activated by nitric oxide (Zhou et al, 2004).The actions of NFE2L2 (see DISC1) are inhibited by TP53 Faraonio et al,2006 |
Associated with schizophrenia in Canadian case and family studies, Chinese and Korean case studies and portugese families (Ni et al., 2005;Park et al., 2004;Yang et al., 2004). |
| TP53I3 tumor protein p53 inducible protein 3 | Binds to TP53:Possible quinone reductase | GWAS Moskvina et al, 2009 |
| Oxidative phosphorylation Complex 1 |
Reported to associate with schizophrenia, particularly in males in a UK case study(Marchbanks et al., 2003). | |
| NDUFV2 24-kDa subunit of Complex I; NADH dehydrogenase (ubiquinone) flavoprotein 2 (24kD) GeneCards |
Oxidative phosphorylation Complex 1 | Association reported in a Japanese study (Waskizuka et al, 2006) |
| UCP2 Uncoupling protein 2 OMIM 601693 GeneCards |
Regulates mitochondrial glutathione levels in microglia (de Bilbao et al, 2004. Binds to YWHAZ | Assocation reported in a Japanese study (Yasuno et al, 2006) |
| UCP4
(SLC25A27) Uncoupling protein 4 GeneCards |
Mitochondrial uncoupling reduces the generation of reactive oxygen species and increases the resistance of cells to oxidative stress (Liu et al, 2006) | Assocation reported in a Japanese study (Yasuno et al, 2006) |
Other related genes: SLC1A2 mediates the glial uptake of the glutathione precursor cysteine and controls glutathione levels (Chen and Swanson, 2003). Quinones can be formed spontaneously from the oxidation of dopamine or from the enzymatic catalysis of dopamine by PTGS2 (arachidonate or H2O2 + dopamine leading to the formation of aminochrome) (Hastings, 1995). COMT methylation of catecholamines prevents quinone generation and COMT methylates dopamine-derived quinones (Zhu, 2004). AKT1, BDNF, CAPON, CCKAR, CHRNA7, CNR1, COMT, DNTBP1, GAD1, GRM3, IL10, MLC1, NOTCH4, NRG1, PRODH, RGS4, RTN4 and TNF, are subject to regulation by hypoxia (Schmidt-Kastner et al, 2006). |
||
| Serotonin related | ||
| HTR1A 5-hydroxytryptamine (serotonin) receptor 1A | US study Huang et al, 2004 | |
| HTR1B 5-hydroxytryptamine (serotonin) receptor 1B | Croatian Study Pal et al, 2009 | |
HTR2A Serotonin receptor OMIM 182135 IUPHAR GeneCards |
Binds
to PSD-95 |
Significant association in a meta-analysis of 31 case-control association studies (Abdolmaleky et al., 2004). |
| HTR2C 5-hydroxytryptamine (serotonin) receptor 2C | Croatian Study Pal et al, 2009 | |
| HTR4 5-hydroxytryptamine (serotonin) receptor 4 | Japanese study Suzuki et al, 2003 | |
| Association reported in Japan (case) and France (family) (Iwata et al., 2001; Dubertret et al 2004) | ||
| Association reported in Taiwan (case study)(Tsai et al., 1999b). | ||
| Association reported in Japan (case study)(Ikeda et al., 2005) | ||
| Binds
to STX1A |
Meta-analysis of 10 separate case studies supports association. | |
| TDO2 tryptophan 2,3-dioxygenase | US Study Miller et al, 2009 | |
TPH1 Tryptophan hydroxylase OMIM 191060 GeneCards |
Activated by YWHAH |
Association reported in American, Japanese and Taiwanese case studies (Hong et al., 2001;Nolan et al., 2000;Sekizawa et al., 2004;Shinkai et al., 2000) |
| YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide [Homo sapiens] | Japanese study Ikeda et al, 2008 | |
| YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase-activation protein, eta polypeptide, 14-3-3 eta. OMIM 113508 GeneCards |
Family members activate TH and TPH1 (inter alia). Associates with GABBR1 (Couve at al, 2001) |
Associates with schizophrenia in a family-based Canadian study (Wong et al., 2003) and with early onset schizophrenia in a Japane case study (Toyooka et al., 1999) . |
| GABA-A receptors and other GABAergic (see above for GABBR1) | ||
|
Associated with childhood-onset schizophrenia in an American family based study (Addington et al., 2005) | |
| GABRA1 gamma-aminobutyric acid (GABA) A receptor, alpha 1 GeneCards | GABA-A receptors are formed from multiple permutations of diverse subunits, of which these are members Bollan et al, 2003 | Petryshen et al, 2005 |
| GABRA6 gamma-aminobutyric acid (GABA) A receptor, alpha 6 GeneCards | Petryshen et al, 2005 | |
| GABRB2 gamma-aminobutyric acid (GABA) A receptor, beta 2 GeneCards | Lo et al, 2004 | |
| GABRP gamma-aminobutyric acid (GABA) A receptor, pi GeneCards | Petryshen et al, 2005 | |
| Other Receptors, peptides, downstream signalling and neurotransmitter metabolising enzymes | ||
ACE Angiotensin converting enzyme (synthesises angiotensin II) OMIM 106180 GeneCards |
Converts angiotensin 1 to angiotensin 2 |
A strong interaction between a low activity COMT genotype and a high activity ACE genotype has been observed in schizophrenic patients non-responsive to neuroleptics. The risk of possessing this combination of polymorphisms is 10 times higher in the schizophrenic non-responsive group (Illi et al., 2003). |
| ADCYAP1 adenylate cyclase activating polypeptide 1 (pituitary)(PACAP) OMIM GeneCards | Enhances NMDA receptor function and increases BDNF expression Yaka et al, 2003 Influences oligodendrocyte proliferation Lelievre et al, 2006. Involved in DISC1 signalingHattori et al, 2007 | Hashimoto et al, 2007 |
| ADIPOR2 adiponectin receptor 2 | GWAS European ancestry Shi et al, 2009 | |
| ADORA1Adenosine A1 receptor | Interacts with DRD1 and GRM1 | Japanese study Gotoh et al, 2009 |
| ADRA1A adrenergic, alpha-1A-, receptor GeneCards | Adrenoceptor: Modulates NMDA recptors via RGS4 Liu et al, 2006 Binds to Neuregulin receptor ERBB3 Thaminy et al, 2003 |
Association reported in a Spanish population (Clark et al,2005) |
| CHAT Choline acetyl transferase GeneCards | Acetlycholine synthesis | Mancama et al, 2007 |
| CHRFAM7A CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion | US Study Sincus et al, 2009 | |
| CHRM5 cholinergic receptor, muscarinic 5 | Canadian study De Luca et al, 2004 | |
| CHRNA4 cholinergic receptor, nicotinic, alpha 4 | Canadian study De Luca et al, 2006 | |
| CHRNA7 Nicotinic receptor alpha subunit OMIM 118511 GeneCards |
Stimulates
glutamate release |
Associated with schizophrenia in American family, French case, South African family and Azorean family studies (Freedman et al., 2001;Houy et al., 2004;Leonard et al., 2002;Raux et al., 2002;Riley et al., 2000;Xu et al., 2001) . |
| CHRNB2 cholinergic receptor, nicotinic, beta 2 (neuronal) | Canadian study De Luca et al, 2006 | |
| Activation inhibits glutamate release (Auclair et al., 2000;Wang, 2003). CNR1 receptor stimulation promotes the survival of oligodendrocyte progenitor cells (Molina-Holgado et al., 2002). |
Association reported in French and Japanese case studies (Leroy et al., 2001;Ujike et al., 2002). | |
| GPR78
Orphan GPCR OMIM 606921 GeneCards |
Orphan receptor | Suggestive association in a Scottish case study (Underwood et al,2006 |
| GPR85 G protein-coupled receptor 85 (SREB2) GeneCards | Orphan receptor: Overexpression reduces brain weight, increases ventricular size and produces schizophrenia-like behavioural effects in mice Matsumoto et al, 2008 | Association in an American family study Matsumoto et al, 2008 |
| HRH2 H2 Histamine receptor |
Histamine receptor |
Associated with schizophrenia in a British case study (Orange et al., 1996). |
| MCHR1 (GPR24) Melanocyte concentrating hormone receptor 1 OMIM 601751 GeneCards | Regulates mesolimbic dopamine signaling Pissios et al, 2008. GRIN1 expression reduced in knockout mice Adamantidis et al, 2005 | Association reported in a Faroese/Scottish
study Severinsen et al, 2006 |
| MCHR2 melanin-concentrating hormone receptor 2 | US study Miller et al, 2009 | |
| MC5R melanocortin 5 receptor | US study Miller et al, 2009 | |
| NPY Neuropeptide Y |
Inhibits
glutamate release |
Associated with schizophrenia in ta Japanese case study (Itokawa et al., 2003a) . |
| OPCML opioid binding protein/cell adhesion molecule-like | GWAS O'Donovan et al, 2008 | |
| Regulates oligodendrocyte differentiation Hayash and Su, 2004 |
Association in a Japanese case study(Ishiguro et al., 1998). | |
| OPRM1 opioid receptor, mu 1 | Czech republic Sery et al, 2010 | |
| Binds to DISC1 (Millar et al., 2005). Activated by NMDA receptors during hippocampal LTP (Ahmed and Frey 2003) |
Disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness (Millar et al., 2005) | |
| PDE4D phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog | Finnish study Tommpo et al, 2009 | |
| PDE7B phosphodiesterase 7B | Japanese and UK study Ikeda et al, 2010 | |
| PDYN Prodynorphin | Chinese study Zhang et al, 2004 | |
| RGS2 regulator of G-protein signaling 2, 24kDa GeneCards | Binds to GNAS | American study Campbell et al, 2008 |
| RGS5 regulator of G-protein signaling 5 GeneCards | American study Campbell et al, 2008 | |
TAAR6 Trace amine receptor 6 (ex 4) OMIM 608923 GeneCards |
Orphan receptor |
Association reported in an American study of european and african american pedigrees(Duan et al., 2004) |
| Adhesion Molecules | ||
| CDH4 Cadherin 4 | International schizophrenia consortium O'Dushlaine et al, 2010 | |
| CHL1 cell adhesion molecule with homology to L1CAM (close homolog of L1) OMIM 607416 GeneCards |
A soluble form of CHL1 promotes neurite extension in cerebellar granule cells (Naus et al., 2004) |
Associates with schizophrenia in a Japanese case study (Sakurai et al., 2002). |
| L1CAM L1 cell adhesion molecule | Japanese studyKuramaji et al, 2001 | |
| CNTNAP2 contactin associated protein-like 2 GeneCards | Member of the neurexin family of adhesion molecules and receptors. Involved in the clustering of potassium channels in myelinated axons Poliak et al, 2002 | Haploinsufficiency in association with epilepsy and schizophrenia in the Amish population Friedman et al, 2007 |
| CNTN1 Contactin 1 | International schizophrenia consortium O'Dushlaine et al, 2010 | |
| GLG1 golgi glycoprotein 1 | International schizophrenia consortium O'Dushlaine et al, 2010 | |
| HLA-DQA2 | International schizophrenia consortium O'Dushlaine et al, 2010 | |
| JAM3 junction adhesion molecule 3 | GWAS Moskvina et al, 2009 | GWAS Moskvina et al, 2009 |
| NCAM1 Neural cell adhesion molecule 1 GeneCards | Promotes assembly of the PSD signaling complex Sytnyk et al, 2006. Stimulates PI3K/AKT signaling (Ditlevsen et al, 2003). TrkB phosphorylation and BDNF signaling is impaired in NCAM knockout mice Muller at al, 2000. Polysialylated-NCAM interacts with BDNF (Vutskits et al, 2001et al. 2001). Oligodendrocytes express GRIN1 and activation of NMDA receptors in these cells increases the expression of polysialylated NCAM1 that is required for oligodendrocyte migration (Wang et al, 1996).Polysialylated by ST8S1A2 Kojima et al, 1996 | Sullivan et al, 2006 |
| NRXN1 Neurexin 1 | International schizophrenia consortium O'Dushlaine et al, 2010 | |
| PDCD1LG2 programmed cell death 1 ligand 2 | International schizophrenia consortium O'Dushlaine et al, 2010 | |
| Tight junction | ||
| CDC42, CTNNA2, HCLS1, HRAS, PRKCH, MYH11, MYH15 and PARD3) |
In progress | International schizophrenia consortium O'Dushlaine et al, 2010 |
| Glycan structures | ||
| MAN2A1, GALNT2, GALNT13, OGT and XYLT1 |
In progress | International schizophrenia consortium O'Dushlaine et al, 2010 |
Snares STX18 and TSNARE1 |
"" | International schizophrenia consortium O'Dushlaine et al, 2010 |
cell cycle MAD1L1 |
"" | International schizophrenia consortium O'Dushlaine et al, 2010 |
| Circadian | ||
| CLOCK circadian locomoter output cycles kaput protein; clock OMIM GeneCards | Controls the expression of ATF4 (see DISC1, GABBR1) Igarashi et al, 2007 Circadian control |
Association repoted in a Japanese study Takao et al, 2007 |
| NPAS2 neuronal PAS domain protein 2 | USA study Mansour et al, 2009 | |
| PER3 period homolog 3 OMIM GeneCards | Circadian control | Association reported in an American study Mansour et al, 2006 |
| TIMELESS OMIM GeneCards | Circadian control | Association reported in an American study Mansour et al, 2006 |
| Glycolysis and Krebs Cycle | ||
| ENO2 Enolase 2 (gamma neuronal) GeneCards | 2-phospho-D-glycerate = phosphoenolpyruvate + H2O |
Association reported in a Scandinavian study Olsen et al, 2008 |
| FBP1 fructose-1,6-bisphosphatase 1 GeneCards | D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate | Association reported in a Scandinavian study Olsen et al, 2008 |
PCK1 phosphoenolpyruvate carboxykinase 1 (soluble) GeneCards |
GTP + oxaloacetate = GDP + phosphoenolpyruvate + CO2 | Association reported in a Scandinavian study Olsen et al, 2008 |
| Cytokines and immune-related | ||
| BTN2A2 butyrophilin, subfamily 2, member A2 | GWAS Shi et al, 2009 | |
| BTN3A1 butyrophilin, subfamily 3, member A1 | GWAS Shi et al, 2009 | |
| BTN3A2 butyrophilin, subfamily 3, member A2 | GWAS Shi et al, 2009 | |
| C3 complement component 3 | Spanish study: Fannanas et al, 1992 | |
| C4A complement component 4A (Rodgers blood group) | UK study Rudduck et al, 1985 | |
| C4B complement component 4B (Chido blood group) | UK study Rudduck et al, 1985 | |
| CFB complement factor B | Spanish study: Fannanas et al, 1992 | |
| CCR5 chemokine (C-C motif) receptor 5 GeneCards | MCP-2, Mip1-alpha and Mip1-beta chemokine receptor expressed on T-cells and macrophages | 32bp deletion associated with late-onset schizophrenia in a Danish study Rasmussen et al, 2006 |
| CD4 CD4 molecule | Belgian study Zamani et al,1994 | |
| CLU Clusterin | Chinese study Zhou at al, 2010 | |
| CSF2RA colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) OMIM GeneCards | receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. | Lencz et al, 2007 |
| CSF2RB colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) GeneCards | Common beta receptor subunit for IL3, IL5 and GM-CSF signaling | Chen et al, 2007 |
| CTLA4 cytotoxic T-lymphocyte-associated protein 4 OMIM 123890 GeneCards |
Member of the immunoglobulin superfamily which transmits an inhibitory signal to T cells |
Association with schizophrenia has been reported in a Korean case study (Jun et al., 2002a). |
| CHI3L1 chitinase 3-like 1 (cartilage glycoprotein-39) Alias: GP39, HC-gp39, HCGP-3P, YKL40, YYL-40 GeneCards | Inhbits effects of TNF and IL1B in peripheral cells Ling and Recklies,2004. Signals via AKT1 Recklies et al,2002 | Zhao et al, 2007 |
| EBF3 Early B-cell factor 3 | GWAS O'Donovan et al, 2008 | |
| IFNG Interferon gamma | Associated in males but not females in a polish study Paul-Samojedny et al, 2010 | |
| IL1A Interleukin 1 alpha | Chinese study Chowdari et al, 2006 | |
| IGH@ immunoglobulin heavy locus | Immunoglobulins recognize foreign antigens and initiate immune responses | Italian study Frezza et al, 2009 |
| Cytokine inducing PTGS2 in the CNS. |
Associated with schizophrenia in Italian, German and Finnish case studies (Katila et al., 1999;Meisenzahl et al., 2001;Zanardini et al., 2003) | |
| IL1RN Interleukin 1 receptor antagonist OMIM 147679 GeneCards |
Inhibits activity of IL1B |
A polymorphism in IL1RA has been reported to exert a protective effect in an Italian case study (Zanardini et al., 2003). Polymorphisms associated with schizophrenia have also been reported in spanish and korean case studies (Kim et al., 2004;Papiol et al., 2005) |
| Cytokine; Stimulates oligodendrocyte proliferation and maturation (Jiang and Lu 1998) |
Association reported in a German case study (Schwarz et al., 2005) | |
| IL3 interleukin 3 (colony-stimulating factor, multiple) OMIM GeneCards | Cytokine ligand for IL3RA | Chen et al, 2007 |
| IL3RA interleukin 3 receptor, alpha (low affinity) OMIM GeneCards | IL3 specific component of a heteromeric receptor unit, that includes CSF2RB | Lencz et al, 2007 Association in a chinese studySun et al, 2008 |
| Association reported in a German case study (Schwarz et al., 2005) | ||
| IL6R Interleukin 6 receptor | Chinese study Sun et al, 2008 | |
| IL9 Interleukin 9 | US study Chen et al, 2008 | |
| IL12B interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) GeneCards | Cytokineimportant for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. | Associated with schizophreniai in an American case-control study Shirts et al, 2008 |
| IL18 interleukin 18 (interferon-gamma-inducing factor) GeneCards | Proinflammatory cytokine inducing interferon-gamma production in T-cells, Binds to IL18 R1 and IL18RAP | Associated with schizophrenia and cytomegalovirus seropositivity in an American case-control study Shirts et al, 2008 |
| IL18R1 interleukin 18 receptor 1 GeneCards | Il18 cytokine recptor: expression induced by IL12 | Associated with schizophrenia and with cytomegalovirus seropositivity in an American case-control study Shirts et al, 2008 |
| Potentiates the IL18 binding activity of IL18R1 (IL1RRP), a ligand binding subunit of the IL18 receptor | Associated with schizophrenia and HSV-1 and cytomegalovirus seropositivity in an American case-control study Shirts et al, 2008 | |
LTA Lymphotoxin alpha OMIM 153440 GeneCards |
Associates with schizophrenia in a Korean case study (Jun et al., 2003). | |
| Anti-inflammatory Cytokine: Protective effects on oligodendrocytes Generally represses effects of TNF and IL1B |
Promoter polymorphisms have been associated with schizophrenia in Italy (case) and China (case and family) (Chiavetto et al., 2002) (He et al., 2006;Jun et al., 2002b;Yu et al., 2004). | |
| IL10RA Interleukin 10 receptor GeneCards | IL10 receptor signalling via AKT pathway | Association reported in an Austrian case study Schosser et al, 2006 |
| Proinflammatory cytokine: Expression controlled by NFE2L1 in mice (Prieschl et al, 1998 (see DISC1). Toxic effects on oligodendrocytes () |
Association reported in Chinese case, male Finnish case, German family, Italian case and Singaporean case studies (Boin et al., 2001b;Boin et al., 2001a;Hanninen et al., 2005b;Schwab et al., 2003;Tan et al., 2003;Zhang et al., 2005) | |
| TNFR2 = TNFRSF1B | TNF receptor | Thabet et al, 2010 |
| TRAF3IP1 TNF receptor-associated factor 3 interacting protein 1 | Binds to DISC1 | Finnish study (stage 1)Tomppo et al, 2009 |
| HLA-A (HLA-A10) major histocompatibility complex, class I, A GeneCards | Immune system | In association with chlamydophila infection Fellerhoff et al, 2007 |
| HLA-B major histocompatibility complex, class I, B GeneCards | Immune system | HLA-B maternal-fetal genotype-matching effect on schizophrenia demonstrated for female offspring : related to birth complications rather than schizophrenia (see environmental risk factors) Palmer et al, 2006 |
HLA-DRB1 DRB1*04major histocompatibility complex, class II, DR beta 1 OMIM 142857 |
HLA-DRB1 recognises peptides generated from myelin oligodendrocyte glycoprotein (MOG) (Weissert et al., 2002). It also recognises peptides derived from the influenza virus (Hennecke and Wiley, 2002;Wedderburn et al., 1995) , from the spirochete Borrelia burgdorferi (Steere et al., 2003;Willett et al., 2004) which causes Lyme disease carried by Ixodes ticks and from peptides derived from the Rubella virus (Neepom et al, 1997) |
The
frequency of this allele is positively associated with rheumatoid arthritis
(Reveille, 1998)and reduced in schizophrenic patients and their healthy
mothers (Wright et al., 1996). The incidences of schizophrenia and rheumatoid
arthritis are inversely correlated (Eaton
et al., 1992;Gorwood
et al., 2004;Vinogradov
et al., 1991). Association also reported in chinese family (Yu et al,2003 and 2 Japanese case studies (Sasaki et al,1999; Arinami et al, 1998 and in Kuwaiti arabs (case study) Heider et al,2000 |
| HLADQA1 major histocompatibility complex, class II, DQ alpha 1 | GWAS Shi et al, 2009 | |
| MICB MHC class I polypeptide-related sequence B OMIM GeneCards | ligand for the NKG2D type II receptor of natural killer cells. | Associated with Herpes virus seropositivity and schizophrenia Shirts et al, 2007 |
| PRSS16 protease, serine, 16 (thymus) | Thought to play a role in the alternative antigen presenting pathway used by cortical thymic epithelial cells during the positive selection of T cells. | GWAS Shi et al, 2009 |
| TGIF1 TGFB-induced factor homeobox 1 GeneCards | Transcriptional repressor of SMAD signaling (part of the TGF beta pathway) and of retinoic acid receptor(RXRalpha) signaling (See Zaharieva et al, 2008 for potential association with SMAD5 or TGFB1. | Association reporterd in an American study Chavarria-Siles et al, 2007 |
| Protein sorting and ER stress | ||
| CALR Calreticulin | Calcium storage protein in the endoplasmic reticulum | Point mutation obsreved in a single schizophrenia patient (1/100) and not in 280 controls Aghajani et al, 2006 |
| HSPA1B HSP70-2 GeneCards | Heat shock protein (molecular chaperones that assist other proteins in their folding, transport and assembly into complexes) | Association suggested in a Korean study Pae et al, 2005 |
| HSPA1L heat shock 70kDa protein 1-like GeneCards | see above | Association in a Korean case-control study Kim et al, 2008 |
| Endoplasmic reticulum stress |
Associated with schizophrenia in Chinese and Japanese case studies (Chen et al., 2004c;Kakiuchi et al., 2004) | |
| WNT Signalling | ||
| DAAM1 dishevelled associated activator of morphogenesis 1 | UK study Proitsi et al, 2008 | |
| DAAM2 dishevelled associated activator of morphogenesis 2 | UK study Proitsi et al, 2008 | |
| DKK4 dickkopf homolog 4 GeneCards | Role in Wnt signaling | Association in chinese trios and a Hong Kong case study Proitsi et al, 2008 |
| Receptor for wingless |
Associated with schizophrenia in Japanese case and Chinese case and family studies (Katsu et al., 2003;Yang et al., 2003a;Zhang et al., 2004) . | |
| KREMEN1 kringle containing transmembrane protein 1 | Binds to DKK1 | Association in a Japanese study Aleksic et al, 2010 |
| SFRP1 secreted frizzled-related protein 1 | UK study Proitsi et al, 2008 | |
| Extracellular matrix proteins, structural , intracellular transport and related | ||
| CAPZA2 capping protein (actin filament) muscle Z-line, alpha 2 | US study Burdick et al, 2010 | |
| FLNB Filamin B | Binds to actin cytoskeleton | UK study Proitsi et al, 2008 |
| ITGA3 integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) GeneCards | Component of an integrin receptor interacting with several extracellular matrix proteins. Binds to CALR | Scandinavian case-control Kahler et al, 2008 |
| KIF2A kinesin heavy chain member 2A | Microtubule-associated motor protein | Chinese study Li et al, 2006 |
| MAP4 microtubule-associated protein 4 | Chinese study So et al, 2009 | |
| MAP6 Microtubule-associated protein 6 OMIM 601783 GeneCards |
Calmodulin-binding and calmodulin-regulated protein involved in microtubule stabilization. |
Associated
in a Japanese case study Shimizu et al, 2006 |
| MYH9 myosin, heavy chain 9, non-muscle | Association in a Chinese study Liu et al, 2008 | |
| MYO9B Myosin IXb GeneCards | Myosin motor | Association reported in a Dutch study Jungerius et al, 2007 |
| MYO18B Myosin XVIII b | US study Purcell et al, 2009 | |
| MXRA5 matrix-remodelling associated 5 | GWAS European ancestry Shi et al, 2009 | |
| RELN Reelin GeneCards | Secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. Signals via PI3K AKT1 pathway, inter alia Jossin and Goffinet, 2007 Controls the surface expression of NMDA receptors (GRIN1, GRIN2B) Groc et al, 2007 and AMPA receptors Qiu and Weeber, 2007 |
Associated with working memory in Finnish schizophrenia families Wedenoja et al, 2007 and in GWAS in women Shifman et al, 2008 |
| SPARCL1 SPARC-like 1 (mast9, hevin) GeneCards | Extracellular matrix protein localised in postsynaptic terminals and enveloping glia Liveley et al, 2007 | |
| TNXB: tenascin XB |
Exracellular matrix protein |
SNP's within the TNXB locus associate with schizophrenia in a UK family based study (Wei and Hemmings, 2004c) |
| Retinol Metabolism | ||
| ADH1B alcohol dehydrogenase IB (class I), beta polypeptide OMIM 103720 GeneCards |
Multiple substrates include catecholamine metabolites. |
Association in a Chinese case study (Xu et al., 2004) and an American family study (Vawter et al, 2006) |
| ALDH1A2 aldehyde dehydrogenase 1 family, member A2 | Catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. | Chinese study Wan et al, 2010 |
| CYP1A2
cytochrome P450, family 1, subfamily A, polypeptide 2 |
Turkish study Boke et al, 2007 | |
| CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 | Chinese study Du et al, 2009 | |
| CYP3A5 cytochrome P450, family 3, subfamily A, polypeptide 5 | Chinese study Du et al, 2009 | |
| RBP1 Retinol binding protein 1, cellular GeneCards | Retinol (Vitamin A alcohol) transport | Genome-wide UK associationstudy using pooled samples Kirov et al, 2008 |
| Ion Channels | ||
| CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit | UK Study Green et al 2009 | |
| CACNA1F calcium channel, voltage-dependent, L type, alpha 1F subunit | UK study Wei et al, 2006 | |
| CACNG2 calcium channel, voltage-dependent, gamma subunit 2 [ | Related to DLG4, GRIA1, GRIA4 and GRIN1 | Association in a Chinese study Liu et al, 2008 |
| KCNH2potassium voltage-gated channel, subfamily H (eag-related), member 2 | US study Hiffaker et al, 2009 | |
| NALCN sodium leak channel, non-selective | GWAS Wang et al, 2010 | |
| TRPA1 transient receptor potential cation channel, subfamily A, member 1 | Cannabinoid receptor-operated channel Jordt et al, 2004 | GWAS African American Shi et al, 2009 |
| Mitochondrial Genes | ||
| ATP6 mitochondrially encoded ATP synthase 6 | Japanese study Ueno et al, 2009 | |
| CYTB mitochondrially encoded cytochrome b | Oxidative phosphorylation | Swedish study Lindholm et al, 1997 |
| MT-haplo | ||
| ND2 mitochondrially encoded NADH dehydrogenase 2 | Oxidative phosphorylation | US study Rollins et al, 2009 |
| ND4 mitochondrially encoded NADH dehydrogenase 4 | Oxidative phosphorylation | UK study Marchbanks et al, 2003 |
| RNR1 mitochondrially encoded 12S RNA | US study Rollins et al, 2009 | |
| Transporters | ||
| ABCA13 ATP-binding cassette, sub-family A (ABC1), member 13 | UK study Knight et al, 2009 | |
| SLCO6A1 solute carrier organic anion transporter family, member 6A1 | GWAS Stefansson et al, 2009 | |
| SLC12A2
solute carrier family 12 (sodium/potassium/chloride transporters), member
2 |
GWAS USA Potkin et al, 2009 | |
| SLC17A1 solute carrier family 17 (sodium phosphate), member 1 | GWAS Shi et al, 2009 | |
| SLC17A3 solute carrier family 17 (sodium phosphate), member 3 | GWAS Shi et al, 2009 | |
| Nuclear import export | ||
| IPO5 Importin 5 | Chinese study Wang et al, 2010 | |
| KPNA3 karyopherin alpha 3 (importin alpha 4) OMIM 601892 GeneCards |
Nuclear
transport: Involved in the nuclear import of Influenza viral
nucleoprotein Melen
et al, 2003 |
Associated
in a British family study (Wei and Hemmings, 2005b) |
|
OMIM 602008 |
Nuclear transport : Important role in the nuclear import of Influenza viral RNA polymerase Deng et al, 2006 | Associated in a British family study (Wei and Hemmings, 2004c) |
| RANBP1 RAN binding protein 1 | Ran involved in nucleocytoplasmic transport Yudin et al, 2009 | USA study Liu et al, 2002 |
| MicroRNA | ||
| MIR-30E microRNA | Xu et al, 2010 | |
| MIR-198 MicroRNA (Link is to Sanger Mirbase) | Hansen et al, 2007 (PLOS) | |
| MIR-206 MicroRNA (Link is to Sanger Mirbase) | Hansen et al, 2007 (PLOS) | |
| Miscellaneous | ||
| ACSL6 acyl-CoA synthetase long-chain family member 6 | US study Chen et al, 2006 | |
| ACSM1 acyl-CoA synthetase medium-chain family member 1 (same as BUCS1) | Butanoate metabolism Kegg | GWAS Sullivan et al, 2008 |
| ADAM12
ADAM metallopeptidase domain 12 |
GWAS O'Donovan et al, 2009 | |
| ADSS adenylosuccinate synthase | Converts IMP to AMP | Zhang et al, 2008 |
| AGA aspartylglucosaminidase GeneCards |
N-glycan degradation : Impaired myelinisation in AGA knockout mice . (Tenhunen et al, 1998) |
Linkage in an American family study related to expression change (Vawter et al, 2006) |
| AGBL1 ATP/GTP binding protein-like 1 [ | GWAS Sullivan et al, 2008 | |
| AHI1 Abelson helper integration site 1GeneCards |
Required for cerebellar and cortical development | Association reported in an Arab-Israeli family (Amman-Zankelstein et al, 2006 |
| AMACR alpha-methylacyl-CoA racemase | Bespalova et al,2010 | |
| ANK3 Ankyrin 3 | Binds to L1CAM Hortsch et al, 2009 | Althanasiu et al, 2010 |
| ANKK1 ankyrin repeat and kinase domain containing 1 | French study Dubertret et al, 2010 | |
| Lipoprotein involved in cholesterol transport. Binds to and potentiates actions of CNTF. Involved in the cerebral uptake of Herpes simplex virus Burgos et al, 2006 |
Increased frequency of the APOE4 allele reported in a British study (Harrington et al., 1995a) and associated with earlier age of onset an American studies (Arnold et al., 1997;Martorell et al., 2001). A decreased frequency of the APOE2 allele has been associated with early onset schizophrenia in Japan (Kimura et al., 1997) and an increased frequency of APOE3 has been reported in China (Chen et al., 1999). A Chinese study has also shown that increased frequency of the APOE4 allele and decreased frequency of APOE3 are associated with schizophrenia. This association is modified by date of birth and restricted to individuals born during times of famine (Liu et al., 2003a). | |
| APOL2 Apolipoprotein L,2 | Japanese study: Takahishi et al, 2008 | |
| AR Androgen receptor | UK study Crow et al, 1993 | |
| ARHGAP18 Rho GTPase activating protein 18 | US study Potkin et al, 2009 | |
| ARHGEF10
Rho guanine nucleotide exchange factor (GEF) 10 |
Dutch study: Jungerius et al, 2008 | |
| ARRB1 arrestin, beta 1 | GWAS Moskvina et al, 2009 | |
| ASTN1 Asrotactin 1 GeneCards | Role in neuronal migration Adams et al, 2002 | Scandinavian case-control Kahler et al, 2008 |
| ASTN2 Astrotactin 2 | Copy number variation Vrijenhioek et al, 2008 | |
| ATE1 arginyltransferase 1 | Involved in ubiquitination | GWAS O'Donovan et al, 2009 |
| ATF4 activating transcription factor 4 (tax-responsive enhancer element B67) (CREB2) | Binds to DISC1 and GABBR1 . Key transcription factor activated by stress-provoked eif2alpha phosphorylation (see EIS2S1) Rutkowski and Kaufman, 2003 and eif2b page | Associated with male patients in a Chinese case control study Qu et al, 2008 |
| ATG9B ATG9 autophagy related 9 homolog B | US study Huffaker et al, 2009 | |
| ATM ataxia telangiectasia mutated | Chinese polulation Zhang et al, 2008 | |
| ATN1 Atrophin1 | German study Morris-Rosendahl et al, 1997 | |
| ATXN3 Ataxin 3 | Binds to PICK1 | Yugoslavian study Culjkovic et al, 2000 |
| B3GAT1 beta-1,3-glucuronyltransferase 1 (Synthesises HNK-1) OMIM 151290 GeneCards |
Key enzyme in the biosynthesis of the carbohydrate epitope HNK-1 (human natural killer-1, also known as CD57 and LEU7). HNK-1 is a component of MOG. Mice deficient in HNK-1 show reduced hippocampal LTP (Mikol et al., 1990;Yamamoto et al., 2002)
|
Located at a chromosomal breakpoint whose translocation (t(6;11)(q14.2;q25) ) segregates with a schizophrenia-like psychosis (Jeffries et al., 2003). |
| BAK1 BCL2-antagonist/killer 1 | UK study Proitsi et al, 2008 | |
| BRD1 Bromodomain containing 1 GeneCards |
Binds to FEZ1 (Assmann et al, 2006) | Association reported
in a Danish case control study Severinsen et al, 2006) |
| BZRP TSPO translocator protein (18kDa) aka peripheral benzodiazepine receptor GeneCards | Important role in controlling cholesterol import into mitochondria and steroid biosynthesis. | Fallin et al., 2005 |
C6orf85=SLC22A23solute carrier family 22, member 23 [ |
GWAS Moskvina et al, 2009 | |
| C10orf120 |
GWAS O'Donovan et al, 2009 | |
| C18orf1 |
Iceland study Ingason et al, 2007 | |
| CBX2 chromobox homolog 2 (Pc class homolog, Drosophila) | GWAS African American Shi et al, 2009 | |
| CCDC60 coiled-coil domain containing 60 GeneCards | Unknown function | Genome-wide UK associationstudy using pooled samples Kirov et al, 2008 |
| CCDC102B coiled-coil domain containing 102B | GWAS Moskvina et al, 2009 | |
| CDC42SE2 CDC42 small effector 2 | US study Chen et al, 2006 | |
| CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | GWAS Moskvina et al, 2009 | |
| CENTG2= AGAP1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 | GWAS European ancestry Shi et al, 2009 | |
| Tight junction protein involved in blood-brain barrier regulation |
Associated in Chinese and British family studies (Sun et al., 2004;Wei and Hemmings, 2005) | |
| CLINT1clathrin interactor 1 | Intracellular traffic | UK study Pimm et al, 2005 |
| CPXM2 carboxypeptidase X (M14 family), member 2 | UK GWAS O'Donovan et al, 2009 | |
| CTNND2 catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein) | Copy number variation Vrijenhioek et al, 2008 | |
| CREB3L1 cAMP responsive element binding protein 3-like 1 | GWAS Moskvina et al, 2009 | |
| CTXN3 Cortexin 3 5q23.2 | GWAS USA Potkin et al, 2009 | |
| CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 [ | Spanish study Llerena et al, 2007 | |
| DDX31 DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 | RNA Helicase | GWAS African American Shi et al, 2009 |
| DGCR2 DiGeorge syndrome critical region gene 2 | UK study Shifman et al, 2006 | |
| DGCR5 DiGeorge syndrome critical region gene 5 | UK study Shifman et al, 2006 | |
| DGCR6 DiGeorge syndrome critical region gene 6 | Binds to GABBR1 | US study Liu et al, 2006 GWAS Moskvina et al, 2009 |
| DLX1 distal-less homeobox 1 GeneCards | Homeobox gene implcated in TGF beta signaling. Role in the migration of GABA neurones to the cortex Cobos et al, 2007. Negatively regulates OLIG2-dependent oligodendrocyte development Petryniak et al, 2007 | Scandinavian case-control Kahler et al, 2008 |
| DNMT3B DNA (cytosine-5-)-methyltransferase 3 beta | Chinese study Zhang et al, 2005 | |
| DYM Dymeclin | Japanese study Yazaki et al, 2010 | |
| ELP3 elongation protein 3 homolog (S. cerevisiae) | GWAS African American Shi et al, 2009 | |
| EML5 echinoderm microtubule associated protein like 5 | GWAS European ancestry Shi et al, 2009 | |
| ENAH enabled homolog (Drosophila) GeneCards | Regulates the actin skeleton Menzies et al, 2004 | Scandinavian case-control Kahler et al, 2008 |
| ESD Esterase D | Spanish study Fananas et al, 1990 | |
| ESR1 estrogen receptor 1 GeneCards | Interacts with TP53: activated by XBP1(see gene data):Phoshorylated by EGFR activation Marquez et al, 2007 |
American case control Weickert et al, 2008 |
| EVPL Envoplakin | GWAS Moskvina et al, 2009 | |
| FABP7 fatty acid binding protein 7, brain GeneCards | Fatty acid binding protein: Target of PAX6 Arai et al, 2005 | Association reported in a Japanese study Watanabe et al, 2007 |
| FBXL21 F-box and leucine-rich repeat protein 21 GeneCards | F-box proteins are subunits of the "SKP1-cullin-F-box" ubiquitin protein ligase complex. Role in phosphorylation-dependent ubiquitinati | |